We are live on ! Find out more
PDLI

PDL BioPharma, Inc.
PDLI

Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

150 hedge funds and large institutions have $318M invested in PDL BioPharma, Inc. in 2019 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 63 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

206% more call options, than puts

Call options by funds: $459K | Put options by funds: $150K

63% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 16

49% more capital invested

Capital invested by funds: $214M → $318M (+$104M)

7% more funds holding

Funds holding: 140 → 150 (+10)

48% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 63

Holders
150
Holders Change
+10
Holders Change %
+7.14%
% of All Funds
2.96%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
26
Increased
33
Reduced
63
Closed
16
Calls
$459K
Puts
$150K
Net Calls
+$309K
Net Calls Change
+$165K

Top Buyers

1
ECM
Engine Capital Management
New York
+$18M
2
VLKIM
Van Lanschot Kempen Investment Management
Netherlands
+$4.53M
3
NM
Newtyn Management
New York
+$4.35M
4
AA
Ancora Advisors
Ohio
+$3.81M
5
CCM
Context Capital Management
California
+$2.07M

Top Sellers

1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$7.13M
2
Morgan Stanley
Morgan Stanley
New York
-$3.85M
3
Renaissance Technologies
Renaissance Technologies
New York
-$3.47M
4
UBS Group
UBS Group
Switzerland
-$3.45M
5
BCM
Bridgeway Capital Management
Texas
-$2.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
KBC Group
51
KBC Group
Belgium
$643K – – –
State of Wisconsin Investment Board
52
State of Wisconsin Investment Board
Wisconsin
$634K – – –
Arrowstreet Capital
53
Arrowstreet Capital
Massachusetts
$630K -$595K -204,950 -51%
CEP
54
Chicago Equity Partners
Illinois
$592K -$978K -336,805 -65%
California State Teachers Retirement System (CalSTRS)
55
California State Teachers Retirement System (CalSTRS)
California
$570K – – –
Marshall Wace
56
Marshall Wace
United Kingdom
$539K -$228K -78,580 -32%
UBS AM
57
UBS AM
Illinois
$517K +$81K +27,919 +21%
OSAM
58
O'Shaughnessy Asset Management
Connecticut
$512K -$187K -64,261 -29%
UBS Group
59
UBS Group
Switzerland
$510K -$3.45M -1,186,838 -88%
Citigroup
60
Citigroup
New York
$498K +$88K +30,311 +25%
SFM
61
Systematic Financial Management
New Jersey
$497K -$284K -97,915 -39%
HHAM
62
HITE Hedge Asset Management
Massachusetts
$488K +$437K +150,412 New
Victory Capital Management
63
Victory Capital Management
Texas
$487K +$185K +63,653 +74%
State Board of Administration of Florida Retirement System
64
State Board of Administration of Florida Retirement System
Florida
$458K -$602K -207,268 -59%
Lazard Asset Management
65
Lazard Asset Management
New York
$458K +$410K +141,208 New
IC
66
IEQ Capital
California
$437K +$391K +134,738 New
JP Morgan Chase
67
JP Morgan Chase
New York
$413K -$1.85M -637,799 -83%
MA
68
MYDA Advisors
New York
$406K +$363K +125,000 New
VRS
69
Virginia Retirement Systems
Virginia
$405K – – –
HW
70
Hancock Whitney
Mississippi
$390K -$280K -96,443 -45%
Barclays
71
Barclays
United Kingdom
$372K -$457K -157,472 -58%
Squarepoint
72
Squarepoint
New York
$370K -$437K -150,636 -57%
Tudor Investment Corp
73
Tudor Investment Corp
Connecticut
$369K -$52.4K -18,043 -14%
Principal Financial Group
74
Principal Financial Group
Iowa
$338K +$19.6K +6,745 +7%
CS
75
Credit Suisse
Switzerland
$330K +$46.7K +16,091 +19%
1 2
3
4 5

PDLI Hedge Fund Activity: Q4 2019 in Review

150 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in PDL BioPharma, Inc. (PDLI) for Q4 2019, worth a combined $318M — up 49% from $214M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new PDLI positions and 16 closed out — a net gain of 10 holders — while 33 added to existing stakes and 63 trimmed.

The largest buyer was Engine Capital Management, opening a new position worth an estimated $18M. The largest seller was Royal Bank of Canada, cutting an estimated $7.13M.

  • 150 institutional investors held PDL BioPharma, Inc. (PDLI) as of Q4 2019, up from 140 in Q3 2019.
  • Funds reported $318M of PDL BioPharma, Inc. stock for Q4 2019, up 49% quarter-over-quarter.
  • 26 funds opened new PDL BioPharma, Inc. positions in Q4 2019 and 16 closed out, a net change of +10 holders.
  • The largest PDL BioPharma, Inc. buyer in Q4 2019 was Engine Capital Management, an estimated $18M added.
  • The largest PDL BioPharma, Inc. seller in Q4 2019 was Royal Bank of Canada, an estimated $7.13M sold.

Based on aggregated 13F filings for Q4 2019.